Viewing Study NCT01839604


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT01839604
Status: COMPLETED
Last Update Posted: 2017-03-06
First Post: 2013-03-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Sponsor: AstraZeneca
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: D5660C00001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View